ArticleOpen medicine : a peer-reviewed, independent, open-access journal2011

Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks.

Dean T Eurich et al.PubMed ↗Full text ↗

No numbers read from the abstract.